学术探索
学术期刊
新闻热点
数据分析
智能评审

Polymorphism of the cytochrome P450 (CYP) 2C9 gene in Japanese epileptic patients:: genetic analysis of the CYP2C9 locus

被引：120
作者：
Imai, J
Ieiri, I
Mamiya, K
Miyahara, S
Furuumi, H
Nanba, E
Yamane, M
Fukumaki, Y
Ninomiya, H
Tashiro, N
Otsubo, K
Higuchi, S
机构：
[1] Tottori Univ, Fac Med, Dept Hosp Pharm, Yonago, Tottori 6838504, Japan
[2] Tottori Univ, Ctr Gene Res, Yonago, Tottori 6838504, Japan
[3] Kyushu Univ, Inst Genet Informat, Higashi Ku, Fukuoka, Japan
[4] Kyushu Univ, Fac Med, Div Pharmaceut Sci, Higashi Ku, Fukuoka, Japan
[5] Kyushu Univ, Fac Med, Dept Neuropsychiat, Higashi Ku, Fukuoka, Japan
来源：
PHARMACOGENETICS | 2000年 / 10卷 / 01期
关键词：
CYP2C9; genetic analysis; polymorphism; new mutations; Japanese;
D O I：
10.1097/00008571-200002000-00011
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
[No abstract available]
引用
收藏
页码：85 / 89
页数：5
相关论文
共 13 条
  • [1] Allelic and functional variability of cytochrome P4502C9
    Bhasker, CR
    Miners, JO
    Coulter, S
    Birkett, DJ
    [J]. PHARMACOGENETICS, 1997, 7 (01): : 51 - 58
  • [2] GENE STRUCTURE AND UPSTREAM REGULATORY REGIONS OF HUMAN CYP2C9 AND CYP2C18
    DEMORAIS, SMF
    SCHWEIKL, H
    BLAISDELL, J
    GOLDSTEIN, JA
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1993, 194 (01) : 194 - 201
  • [3] Genetic polymorphism of CYP2C9 and its effect on warfarin maintenance dose requirement in patients undergoing anticoagulation therapy
    Furuya, H
    FernandezSalguero, P
    Gregory, W
    Taber, H
    Steward, A
    Gonzalez, FJ
    Idle, JR
    [J]. PHARMACOGENETICS, 1995, 5 (06): : 389 - 392
  • [4] GOTOH O, 1992, J BIOL CHEM, V267, P83
  • [5] Genetic polymorphism of cytochrome P450s, CYP2C19, and CYP2C9 in a Japanese population
    Kimura, M
    Ieiri, I
    Mamiya, K
    Urae, F
    Higuchi, S
    [J]. THERAPEUTIC DRUG MONITORING, 1998, 20 (03) : 243 - 247
  • [6] The effects of genetic polymorphisms of CYP2C9 and CYP2C19 on phenytoin metabolism in Japanese adult patients with epilepsy: Studies in stereoselective hydroxylation and population pharmacokinetics
    Mamiya, K
    Ieiri, I
    Shimamoto, J
    Yukawa, E
    Imai, J
    Ninomiya, H
    Yamada, H
    Otsubo, K
    Higuchi, S
    Tashiro, N
    [J]. EPILEPSIA, 1998, 39 (12) : 1317 - 1323
  • [7] Genetic polymorphism of the CYP2C subfamily and its effect on the pharmacokinetics of phenytoin in Japanese patients with epilepsy
    Odani, A
    Hashimoto, Y
    Otsuki, Y
    Uwai, Y
    Hattori, H
    Furusho, K
    Inui, K
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 1997, 62 (03) : 287 - 292
  • [8] CLONING AND EXPRESSION OF COMPLEMENTARY DNAS FOR MULTIPLE MEMBERS OF THE HUMAN CYTOCHROME-P450IIC SUBFAMILY
    ROMKES, M
    FALETTO, MB
    BLAISDELL, JA
    RAUCY, JL
    GOLDSTEIN, JA
    [J]. BIOCHEMISTRY, 1991, 30 (13) : 3247 - 3255
  • [9] Genetic analysis of the human cytochrome P450 CYP2C9 locus
    Stubbins, MJ
    Harries, LW
    Smith, G
    Tarbit, MH
    Wolf, CR
    [J]. PHARMACOGENETICS, 1996, 6 (05): : 429 - 439
  • [10] The role of the CYP2C9-Leu(359) allelic variant in the tolbutamide polymorphism
    SullivanKlose, TH
    Ghanayem, BI
    Bell, DA
    Zhang, ZY
    Kaminsky, LS
    Shenfield, GM
    Miners, JO
    Birkett, DJ
    Goldstein, JA
    [J]. PHARMACOGENETICS, 1996, 6 (04): : 341 - 349
12